In April 2015, an FDA advisory panel voted to include new safety information about potential heart failure side effects on the label of the diabetes drug Onglyza (saxaglipton). This was after the panel reviewed the results of the “SAVOR” trial, in which researchers found that…
On September 8, 2015, a New York woman filed a new Bard IVC filter lawsuit against manufacturer C. R. Bard and Bard Peripheral Vascular, Inc. She claims that after being implanted with the filter, which was designed to help prevent blood clots from reaching the…
A recent NBC News report raised serious questions about the safety of Bard IVC filters. These filters are implanted in the inferior vena cava (IVC)—the vein taking blood from the lower legs back to the heart—in patients who are at risk of pulmonary embolism (PE),…
On September 1, 2015, plaintiffs filed another Zofran lawsuit in the Central District of California. Though there has been no Zofran MDL established yet, Zofran manufacturer GlaxoSmithKline (GSK) has filed a motion requesting that all federally filed Zofran lawsuits be brought together in one court…
Cook IVC (inferior vena cava) filters have been under fire lately because of a potential increased risk of vein perforation, device fracture, and migration of pieces to other parts of the body—all instances that can cause life-threatening conditions. In response to an increasing number of…
One of the issues that has come up again and again in prescription drug lawsuits is the fact that many pharmaceutical companies have promoted their drugs for off-label uses not approved by the Food and Drug Administration (FDA). Though doctors can generally prescribe medications as…
In January 2014, the FDA released a drug safety communication announcing they were investigating the risk of serious side effects—including stroke, heart attack, and death—in men taking testosterone replacement products. They released the warning in response to a couple of major studies that had ind
On August 10, 2015, USA Today reported that the death toll from the recent outbreak of Legionnaire’s disease in New York City had reached 12. Mayor Bill de Blasio reported that 113 people in total had been affected, with 76 people hospitalized for the disease.…
Health Canada has completed a safety review of Xarelto (rivaroxaban), a newer-generation anti-coagulant medication manufactured by Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson). According to a Summary Safety Review released on August 26, 2015, the department investigated the medication
Researchers have reported on a serious potential side effect with temporary inferior vena cava (IVC) filters. The small, cage-like devices are inserted into the vena cava vein, which takes deoxygenated blood from the lower legs back to the heart. It is this vein that can…
In June 2015, researchers published a new study on Cook IVC filters. They compared the Cook Celect with the Option filters, and reported the results. Those results raised concerns in the medical community that certain IVC filters, which are used to help prevent pulmonary embolism…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana before the Honorable Judge Fallon. Currently, about 400 cases are pending there. One of the cases recently filed involves a…